Publication:
Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.

dc.contributor.authorGonzalez-Serna, A
dc.contributor.authorGenebat, M
dc.contributor.authorDe Luna-Romero, M
dc.contributor.authorTarancon-Diez, L
dc.contributor.authorDominguez-Molina, B
dc.contributor.authorPacheco, Y M
dc.contributor.authorMuñoz-Fernández, M A
dc.contributor.authorLeal, M
dc.contributor.authorRuiz-Mateos, E
dc.date.accessioned2023-01-25T08:35:00Z
dc.date.available2023-01-25T08:35:00Z
dc.date.issued2016-09-23
dc.description.abstractTROCAI is a phenotypic tropism test developed using the virological response to a short-term exposure to maraviroc monotherapy (Maraviroc Clinical Test [MCT]). It was found that with TROCAI, a cutoff of
dc.identifier.doi10.1128/AAC.01326-16
dc.identifier.essn1098-6596
dc.identifier.pmcPMC5038326
dc.identifier.pmid27480849
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038326/pdf
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5038326?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/10329
dc.issue.number10
dc.journal.titleAntimicrobial agents and chemotherapy
dc.journal.titleabbreviationAntimicrob Agents Chemother
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number6398-401
dc.pubmedtypeJournal Article
dc.pubmedtypeValidation Study
dc.rights.accessRightsopen access
dc.subject.meshCyclohexanes
dc.subject.meshHIV
dc.subject.meshHIV Fusion Inhibitors
dc.subject.meshHumans
dc.subject.meshInhibitory Concentration 50
dc.subject.meshMaraviroc
dc.subject.meshTriazoles
dc.subject.meshViral Tropism
dc.subject.meshVirology
dc.titleValidation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number60
dspace.entity.typePublication

Files